TGFB1 and neoplasm: In diffuse-type gastric carcinoma, TGF-β induces the production of some angiogenic inhibitors, including thrombospondin-1 and TIMP-2, and perturbations of TGF-β signaling may thus lead to induction of angiogenesis and tumor growth in vivo (30,31).